BBIO

BridgeBio Pharma, Inc. $72.44 1M -13.6% 3M +7.2% YTD -7.4% as of 2026-09-11
+Watchlist

↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings ● beat ● miss  ·  ring ◯ before open ◯ after close  · ─ moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.7%
Next 1 week
+1.8%
Next 1 month
-0.6%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Oversold — RSI(2) at 15
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.19%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.12 -0.2% · Seasonal tilt (6y) -0.5%
$156M/day volume 47% volatility +37% 1-year -22% from ATH
52-week range · 53% of the way up · -22% from the high
$48.78$93.42

Congressional trades in BBIO Full tracker →

1 member · 7 buys / 0 sells · $7K–$105K disclosed · latest filing Jun 8, 2026.

BUY GC Gilbert Cisneros · traded May 11, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Apr 29, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Mar 3, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Mar 18, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Mar 19, 2026 $1K–$15K
BUY GC Gilbert Cisneros · traded Sep 22, 2025 $1K–$15K
BUY GC Gilbert Cisneros · traded Aug 8, 2025 $1K–$15K

Earnings Full history →

Next report 2026-10-28 (Wednesday, after close, in 44 days) · EPS est. -0.63.

1-day std dev
7.0%
Finished up
45%
Biggest pop
+25.7%
Biggest drop
-12.5%

Standard deviation of the close-to-close move over the last 29 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.